Ownership Summary
Glucotrack, Inc. (NASDAQ:GCTK) currently has 9 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
- Institutional ownership in Glucotrack edged up to 90.7% in December 2025, compared to 31.5% in September 2025.
- Quarterly data indicates a 188.06% shift in institutional share volume, and the annual owner count reflects a decrease of 18.18%.
- Of these 9 institutional investors, 3 increased their holdings in Glucotrack, while 3 of them reduced positions, and 3 investors maintained their exposure.
- Collectively, institutional investors increased their stake in Glucotrack to 18.14K shares as of December 2025, a change that is up by 11.84K shares quarter on quarter and down 256.78K shares year over year.
- BOOTHBAY FUND MANAGEMENT, LLC's holding of 13.53K shares as of December 31, 2025 makes it the primary institutional investor in Glucotrack, owning 67.61% of the stock.
- Among the most significant buyers of Glucotrack during December 2025 were BOOTHBAY FUND MANAGEMENT, LLC (13.53K), UBS Group AG (79), BANK OF AMERICA CORP /DE/ (21).
- Leading sellers of Glucotrack stock in December 2025 included ALERUS FINANCIAL NA (1.00K), MORGAN STANLEY (400), Tower Research Capital LLC (TRC) (381).
- The top 9 institutional holders of Glucotrack for the quarter ending December 2025 included BOOTHBAY FUND MANAGEMENT, LLC (13.53K), ALERUS FINANCIAL NA (4.00K), Tower Research Capital LLC (TRC) (425), UBS Group AG (119), Newbridge Financial Services Group, Inc. (34), BANK OF AMERICA CORP /DE/ (28), SBI Securities Co., Ltd. (9), OSAIC HOLDINGS, INC. (1), MORGAN STANLEY (1).